Medicare Enrolled

Dr. Laurie Kane, MD

Endocrinology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
12555 W JEFFERSON BLVD STE 301, Los Angeles, CA 90066
4244435588
In practice since 2006 (19 years)
NPI: 1730248956 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kane

Dr. Laurie Kane is an endocrinology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kane performed 615 Medicare services across 399 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kane received a total of $6,542 from 28 pharmaceutical and/or device companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 615 Medicare services $6,542 industry payments

Medicare Practice Summary

Medicare Utilization ↗
615
Medicare services
Bottom 47% in CA for endocrinology
399
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
148 $146 $864
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
130 $3 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $109 $619
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
83 $91 $616
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
54 $30 $162
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
51 $9 $44
New patient office visit, complex (60-74 min) 16 $182 $1,055
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
16 $72 $439
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $140 $801
Online digital E/M service, established patient, 11-20 min
An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days.
11 $23 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,542
Total received (2018-2024)
Avg $935/year across 7 years
Top 25% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,542 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$333
2023
$896
2022
$898
2021
$1,087
2020
$820
2019
$1,501
2018
$1,008

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$193
ABBVIE INC.
$34
Lilly USA, LLC
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
IBSA Pharma Inc.
$22
Amgen Inc.
$15
Nevro Corp.
$14
Top 3 companies account for 77.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,838
Lilly USA, LLC
$1,273
Boehringer Ingelheim Pharmaceuticals, Inc.
$752
Abbott Laboratories
$350
AstraZeneca Pharmaceuticals LP
$337
SANOFI-AVENTIS U.S. LLC
$328
IBSA Pharma Inc.
$272
Dexcom, Inc.
$235
Insulet Corporation
$218
Amgen Inc.
$135
Mannkind Corporation
$126
Horizon Therapeutics plc
$104
ABBVIE INC.
$88
Boston Scientific Corporation
$73
GlaxoSmithKline, LLC.
$63
Medtronic, Inc.
$62
LEO Pharma Inc.
$51
Bayer HealthCare Pharmaceuticals Inc.
$40
Zealand Pharma US, Inc.
$34
Organon LLC
$29
IDORSIA PHARMACEUTICALS US INC
$22
Ultragenyx Pharmaceutical Inc.
$19
Radius Health, Inc.
$19
Gilead Sciences, Inc.
$18
VistaPharm, Inc.
$16
Nevro Corp.
$14
MAYNE PHARMA INC.
$12
Medtronic MiniMed, Inc.
$12
Top 3 companies account for 59.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AREXVY · BAQSIMI · BASAGLAR · BYDUREON · Dexcom CGM · Dexcom G6 Transmitter · EMGALITY · ENSTILAR · EVENITY · FARXIGA · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · HUMALOG · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · JARDIANCE · Kerendia · LICART · LYUMJEV · MOUNJARO · Minimed 670G System · NEXPLANON · Omnipod · Ozempic · QUVIVIQ · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · Saxenda · Senza · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · V-GO DISPOSABLE INSULIN DELIVERY · Victoza · WATCHMAN Access System · Wegovy · ZEGALOGUE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Los Angeles?
Compare endocrinologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
260
Per 100K population
2.6
County median income
$87,760
Nearest hospital
CEDAR-SINAI MARINA DEL REY HOSPITAL
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kane is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kane experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Kane performed 148 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kane receive payments from pharmaceutical companies?
Yes. Dr. Kane received a total of $6,542 from 28 companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kane's costs compare to other endocrinologists in Los Angeles?
Dr. Kane's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →